Aldama Guillermo, López Manuel, Santás Melisa, Flores Xacobe, Piñón Pablo, Salgado Jorge, Calviño Ramón, Vázquez Nicolás, Mesías Alejandro, González-Juanatey Carlos, Muñiz Javier, Vázquez José Manuel
Servicio de Cardiología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Servicio de Cardiología, Hospital Arquitecto Marcide, Ferrol, A Coruña, Spain.
Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):632-642. doi: 10.1016/j.rec.2019.09.031. Epub 2020 Feb 1.
Little is known about the impact of networks for ST-segment elevation myocardial infarction (STEMI) care on the population. The objective of this study was to determine whether the PROGALIAM (Programa Gallego de Atención al Infarto Agudo de Miocardio) improved survival in northern Galicia.
We collected all events coded as STEMI between 2001 and 2013. A total of 6783 patients were identified and divided into 2 groups: pre-PROGALIAM (2001-2005), with 2878 patients, and PROGALIAM (2006-2013), with 3905 patients.
In the pre-PROGALIAM period, 5-year adjusted mortality was higher both in the total population (HR, 1.22, 95%CI, 1.14-1.29; P <.001) and in each area (A Coruña: HR, 1.12; 95%CI, 1.02-1.23; P=.02; Lugo: HR, 1.34; 95%CI, 1.2-1.49; P <.001 and Ferrol: HR, 1.23; 95%CI, 1.1-1.4; P=.001). Before PROGALIAM, 5-year adjusted mortality was higher in the areas of Lugo (HR, 1.25; 95%CI, 1.05-1.49; P=.02) and Ferrol (HR, 1.32; 95%CI, 1.13-1.55; P=.001) than in A Coruña. These differences disappeared after the creation of the STEMI network (Lugo vs A Coruña: HR, 0.88; 95%CI, 0.72-1.06; P=.18, Ferrol vs A Coruña: HR, 1.04; 95%CI, 0.89-1.22; P=.58.
For patients with STEMI, the creation of PROGALIAM in northern Galicia decreased mortality and increased equity in terms of survival both overall and in each of the areas where it was implemented. This study was registered at ClinicalTrials.gov (Identifier: NCT02501070).
关于ST段抬高型心肌梗死(STEMI)护理网络对人群的影响,目前所知甚少。本研究的目的是确定PROGALIAM(加利西亚急性心肌梗死治疗计划)是否能提高加利西亚北部地区的生存率。
我们收集了2001年至2013年间所有编码为STEMI的病例。共识别出6783例患者,并分为两组:PROGALIAM实施前(2001 - 2005年),有2878例患者;PROGALIAM实施期间(2006 - 2013年),有3905例患者。
在PROGALIAM实施前的时期,总体人群的5年校正死亡率较高(风险比[HR],1.22;95%置信区间[CI],1.14 - 1.29;P <.001),且每个地区都是如此(拉科鲁尼亚:HR,1.12;95%CI,1.02 - 1.23;P =.02;卢戈:HR,1.34;95%CI,1.2 - 1.49;P <.001;费罗尔:HR,1.23;95%CI,1.1 - 1.4;P =.001)。在PROGALIAM实施前,卢戈地区(HR,1.25;95%CI,1.05 - 1.49;P =.02)和费罗尔地区(HR,1.32;95%CI,1.13 - 1.55;P =.001)的5年校正死亡率高于拉科鲁尼亚地区。在STEMI网络建立后,这些差异消失了(卢戈地区与拉科鲁尼亚地区相比:HR,0.88;95%CI,0.72 - 1.06;P =.18;费罗尔地区与拉科鲁尼亚地区相比:HR,1.04;95%CI,0.89 - 1.22;P =.58)。
对于STEMI患者,在加利西亚北部建立PROGALIAM降低了死亡率,并在总体以及实施该计划的每个地区提高了生存方面的公平性。本研究已在ClinicalTrials.gov注册(标识符:NCT02501070)。